PTAB Holds Patent Eligible for Post-Grant Review After Petitioner Successfully Demonstrates that Patent Is Not Entitled to Earliest Claimed Priority Date

Sep 12, 2016

Reading Time : 2 min

Under the America Invents Act, PGR is available only for patents that have “at least one claim with an effective filing date on or after March 16, 2013, with ‘effective filing date’ having the definition given to it by 35 U.S.C. § 100(i).” If the effective filing date is prior to March 16, 2013, then the patent is ineligible for PGR. According to 35 U.S.C. § 100(i), the effective filing date is the filing date of the earliest application for which the patented invention is entitled. In instances when a patent is not entitled to any earlier filing date or right of priority, the effective filing date is the filing date of the patent itself. Id. 35 U.S.C. § 100(i).

The parties here disputed the effective filing date of the ’017 patent. The patent owner argued that the ’017 patent was entitled to the benefit of a series of earlier applications, the earliest of which was filed on October 25, 2002. Conversely, petitioner argued that the ’017 patent was not entitled to such benefit and that the effective filing date was March 24, 2014 (i.e., the filing date of the ’017 patent itself). The PTAB agreed with petitioner. Specifically, the PTAB found that all challenged claims require: (1) a heat transfer composition with a low toxicity refrigerant that essentially consists of 2,3,3,3-tetrafluorpropene (HFO-1234yf); (2) a lubricant that consists essentially of polyalkylene glycol(s) (PAG); and (3) a specific heat transfer application—automobile air conditioning. In reaching its determination, the PTAB noted that the earlier filed applications disclosed “blazemarks” to the general use of tetrafluorpropene and PAG lubricants and a “single passing reference” to automobile air conditioning.  However, that was insufficient.  Instead, the PTAB concluded that the earlier filed applications did “not enable the subject matter recited in [the challenged claims]” and failed to “provide sufficient guidance to demonstrate possession of the claimed subject matter as a whole, i.e., the combination of HFO-1234yf and [PAG] lubricant for automobile air conditioning.” Accordingly, the PTAB held that the ’017 patent had an effective filing date of March 26, 2014 and was thus eligible for PGR.

In the event that the ’017 patent was deemed ineligible for PGR, petitioner had also filed an inter partes review petition concurrent with its PGR petition. In view of the above determination, petitioner’s inter partes review petition was denied.

Arkema Inc., et al. v. Honeywell Intl. Inc., Case Nos. PGR2016-00011, Paper No. 13, PGR2016-00012, Paper No. 13, and IPR2016-00643, Paper No. 11 (PTAB, Sep. 2, 2016).

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.